Compare ZNTL & NODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZNTL | NODK |
|---|---|---|
| Founded | 2014 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.3M | 296.3M |
| IPO Year | 2020 | 2017 |
| Metric | ZNTL | NODK |
|---|---|---|
| Price | $1.38 | $13.53 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $5.87 | N/A |
| AVG Volume (30 Days) | ★ 758.1K | 16.6K |
| Earning Date | 11-10-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | $26,865,000.00 | ★ $297,973,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $122.94 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.01 | $12.01 |
| 52 Week High | $3.33 | $16.25 |
| Indicator | ZNTL | NODK |
|---|---|---|
| Relative Strength Index (RSI) | 47.91 | 45.95 |
| Support Level | $1.33 | $13.92 |
| Resistance Level | $1.46 | $14.70 |
| Average True Range (ATR) | 0.07 | 0.48 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 33.33 | 31.18 |
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
NI Holdings Inc is a stockholding company. The company's operating segments include private passenger auto insurance, non-standard auto insurance, home and farm insurance, crop insurance, commercial insurance, and others. The company operates only in USA.